This Article Full Text Full Text (PDF) All Versions of this Article: 97/9/891    most recent 01.RES.0000187469.82595.15v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, L. Articles by Xia, P. Search for Related Content PubMed PubMed Citation Articles by Wang, L. Articles by Xia, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB STREPTOZOTOCIN Related Collections Pathophysiology Cell signalling/signal transduction Type 1 diabetes Type 2 diabetes Other Vascular biology

(Circulation Research. 2005;97:891.)
© 2005 American Heart Association, Inc.

Molecular Medicine

Activation of the Sphingosine Kinase–Signaling Pathway by High Glucose Mediates the Proinflammatory Phenotype of Endothelial Cells

Lijun Wang, Xiao-Ping Xing, Andrew Holmes, Carol Wadham, Jennifer R. Gamble, Mathew A. Vadas, Pu Xia

From the Signal Transduction Laboratory (L.W., A.H., C.W., J.R.G., M.A.V., P.X.), Division of Human Immunology, Hanson Institute, Institute of Medical and Veterinary Science, Adelaide, Australia; Department of Medicine (J.R.G., M.A.V., P.X.), University of Adelaide, Australia; and Department of Endocrinology (X.-P.X.), Peking Union Medical College Hospital, Beijing, China.

Correspondence to Pu Xia, MD, Hanson Institute, Frome Rd, Adelaide, SA 5000, Australia. E-mail pu.xia{at}imvs.sa.gov.au

Vascular endothelial cells are key targets for hyperglycemic damage that facilitates vascular inflammation and the vasculopathy associated with diabetes mellitus. However, the mechanisms underlying this damage remain undefined. We now demonstrate that hyperglycemia induces activation of sphingosine kinase (SphK), which represents a novel signaling pathway that mediates endothelial damage under ambient high glucose conditions. SphK activity was significantly increased in aorta and heart of streptozotocin-induced diabetic rats. Interestingly, this increase in SphK activity was prevented by insulin treatment, which achieved euglycemia in the diabetic animals. Hyperglycemia-induced increase in SphK activity was also evident in endothelial cells that received long-term exposure to high glucose (22 mmol/L). Studies using a small interfering RNA strategy demonstrated that endogenous SphK1, but not SphK2, is the major isoenzyme that was activated by high glucose. In addition, an increase in SphK1 phosphorylation was detected in a protein kinase C– and extracellular signal–regulated kinase 1/2–dependent manner, which accounts for the high glucose–induced increases in SphK activity. Importantly, inhibition of SphK1 by either a chemical inhibitor (N',N'-dimethylsphingosine) or expression of a dominant-negative mutant of SphK1 (SphK^G82D), or SphK1-specific small interfering RNA, strongly protected endothelial cells against high glucose–induced damage, as characterized by an attenuation in the expression of proinflammatory adhesion molecules, adhesion of leukocytes to endothelial cells, and nuclear factor B activation. Thus, interventions that target the SphK-signaling pathway may have the potential to prevent vascular lesions under hyperglycemic conditions.

Key Words: diabetes • endothelial cells • hyperglycemia • sphingosine kinase • vascular inflammation

This article has been cited by other articles:

				M. Tauseef, V. Kini, N. Knezevic, M. Brannan, R. Ramchandaran, H. Fyrst, J. Saba, S. M. Vogel, A. B. Malik, and D. Mehta Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial Cells Circ. Res., November 7, 2008; 103(10): 1164 - 1172. [Abstract] [Full Text] [PDF]

				F. Feng, L. Wang, N. Albanese, A. Holmes, and P. Xia Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Attenuates the Action of Insulin in Hepatocytes Endocrinology, April 1, 2008; 149(4): 1505 - 1513. [Abstract] [Full Text] [PDF]

				X. Li, M. Stankovic, C. S. Bonder, C. N. Hahn, M. Parsons, S. M. Pitson, P. Xia, R. L. Proia, M. A. Vadas, and J. R. Gamble Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1 Blood, April 1, 2008; 111(7): 3489 - 3497. [Abstract] [Full Text] [PDF]

				C. Wadham, A. Parker, L. Wang, and P. Xia High Glucose Attenuates Protein S-Nitrosylation in Endothelial Cells: Role of Oxidative Stress Diabetes, November 1, 2007; 56(11): 2715 - 2721. [Abstract] [Full Text] [PDF]

				B. You, A. Ren, G. Yan, and J. Sun Activation of Sphingosine Kinase-1 Mediates Inhibition of Vascular Smooth Muscle Cell Apoptosis by Hyperglycemia Diabetes, May 1, 2007; 56(5): 1445 - 1453. [Abstract] [Full Text] [PDF]

				J. E. Kanter, F. Johansson, R. C. LeBoeuf, and K. E. Bornfeldt Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques? Circ. Res., March 30, 2007; 100(6): 769 - 781. [Abstract] [Full Text] [PDF]